Victor Gura is a Nephrology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 44 publications with 1,794 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
99 N La Cienega Blvd
Suite 203
Beverly Hills, CA 902112222
Telephone
310-550-6240Registry record last updated 29 May 2019.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BridgeBio Pharma, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Outset Medical IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
39%Beta blocker7.5%Nebivolol Hcl28%Metoprolol Succinate26%Labetalol Hcl25%Metoprolol Tartrate15%Carvedilol6%Part D<11 patientsAngiotensin receptor blocker (ARB)7.3%Olmesartan Medoxomil68%Edarbi19%Telmisartan7%Losartan Potassium6%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
25.8%SGLT2 inhibitor5.3%Jardiance100%Part D≥27 patientsProton pump inhibitor4.5%Pantoprazole Sodium31%Omeprazole25%Dexlansoprazole Dr24%Omeprazole-Sodium Bicarbonate20%Part D<11 patients+ 10 more classes in this area
Nervous system
14.2%Gabapentinoids3.4%Pregabalin81%Gabapentin19%Part D<11 patientsAntihistamine3.1%Hydroxyzine Hcl100%Part D≥21 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Dialyzing at home with a new model of the Wearable Artificial Kidney
Wearable Artificial Organs, Inc.
FY2025$1,407,179R44DK139891 - Dialyzing at home with a new model of the Wearable Artificial Kidney
Wearable Artificial Organs, Inc.
FY2024$459,824R44DK139891
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ToxiPedia: A Website Research and Education Tool on Uremic Toxins
Journal of the American Society of Nephrology
2023 - Uremic Toxins Are Adsorbed by the Model 3 Wearable Artificial Kidney (WAK)
Journal of the American Society of Nephrology
2023 - A 20-lb Portable Continuous Renal Replacement Therapy (PCRRT) Machine Battery Operated Using 300 mL Fluid: CRRT Anywhere, Any Time
Journal of the American Society of Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Beth Karlan, MD
Cedars-Sinai Medical Center
Raj Makkar, MD
Cedars-Sinai Medical Center
Paul Noble, MD
Cedars-Sinai Medical Center
Stephen Freedland, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”